Gregory S. Cole Sells 2,350 Shares of K2M Group Holdings, Inc. (KTWO) Stock

K2M Group Holdings, Inc. (NASDAQ:KTWO) CFO Gregory S. Cole sold 2,350 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $24.08, for a total transaction of $56,588.00. Following the transaction, the chief financial officer now directly owns 55,158 shares of the company’s stock, valued at $1,328,204.64. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Gregory S. Cole also recently made the following trade(s):

  • On Friday, August 11th, Gregory S. Cole sold 39,357 shares of K2M Group Holdings stock. The stock was sold at an average price of $23.37, for a total transaction of $919,773.09.
  • On Saturday, July 1st, Gregory S. Cole sold 956 shares of K2M Group Holdings stock. The stock was sold at an average price of $24.33, for a total transaction of $23,259.48.

K2M Group Holdings, Inc. (NASDAQ:KTWO) traded down 0.46% during trading on Friday, hitting $23.65. 49,821 shares of the company traded hands. The stock has a 50-day moving average price of $24.02 and a 200-day moving average price of $22.00. K2M Group Holdings, Inc. has a 12-month low of $15.45 and a 12-month high of $25.99. The firm’s market capitalization is $1.02 billion.

K2M Group Holdings (NASDAQ:KTWO) last announced its quarterly earnings results on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.22) by $0.01. K2M Group Holdings had a negative return on equity of 15.45% and a negative net margin of 16.21%. The business had revenue of $65.70 million during the quarter, compared to the consensus estimate of $66.26 million. During the same quarter in the prior year, the company posted ($0.27) earnings per share. K2M Group Holdings’s revenue was up 11.0% compared to the same quarter last year. Equities analysts expect that K2M Group Holdings, Inc. will post ($0.78) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This story was first published by Community Financial News and is owned by of Community Financial News. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://www.com-unik.info/2017/08/18/gregory-s-cole-sells-2350-shares-of-k2m-group-holdings-inc-ktwo-stock.html.

A number of large investors have recently made changes to their positions in the company. TimesSquare Capital Management LLC increased its stake in shares of K2M Group Holdings by 31.5% in the second quarter. TimesSquare Capital Management LLC now owns 2,888,020 shares of the medical device company’s stock valued at $70,352,000 after buying an additional 691,000 shares during the period. Citadel Advisors LLC increased its stake in shares of K2M Group Holdings by 3,357.5% in the first quarter. Citadel Advisors LLC now owns 628,808 shares of the medical device company’s stock valued at $12,897,000 after buying an additional 610,621 shares during the period. JPMorgan Chase & Co. increased its stake in shares of K2M Group Holdings by 54.3% in the first quarter. JPMorgan Chase & Co. now owns 1,409,360 shares of the medical device company’s stock valued at $28,906,000 after buying an additional 495,749 shares during the period. Next Century Growth Investors LLC increased its stake in shares of K2M Group Holdings by 134.8% in the first quarter. Next Century Growth Investors LLC now owns 553,654 shares of the medical device company’s stock valued at $11,355,000 after buying an additional 317,878 shares during the period. Finally, Point72 Asset Management L.P. increased its stake in shares of K2M Group Holdings by 114.0% in the first quarter. Point72 Asset Management L.P. now owns 555,500 shares of the medical device company’s stock valued at $11,393,000 after buying an additional 295,900 shares during the period. Institutional investors and hedge funds own 98.55% of the company’s stock.

Several equities analysts have recently weighed in on the stock. Cowen and Company set a $28.00 price target on shares of K2M Group Holdings and gave the stock a “buy” rating in a research note on Thursday. Zacks Investment Research raised shares of K2M Group Holdings from a “sell” rating to a “hold” rating in a research note on Saturday, August 5th. Needham & Company LLC reissued a “buy” rating on shares of K2M Group Holdings in a research note on Wednesday, August 2nd. Oppenheimer Holdings, Inc. set a $29.00 target price on shares of K2M Group Holdings and gave the company a “buy” rating in a research note on Wednesday, August 2nd. Finally, BidaskClub cut shares of K2M Group Holdings from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Two analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $26.50.

About K2M Group Holdings

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Insider Buying and Selling by Quarter for K2M Group Holdings (NASDAQ:KTWO)

What are top analysts saying about K2M Group Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for K2M Group Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit